日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

针对hu14.18K322A mAb Fc区的预存抗治疗抗体与复发性神经母细胞瘤患者的预后相关。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-000590
Goldberg, Jacob L; Navid, Fariba; Hank, Jacqueline A; Erbe, Amy K; Santana, Victor; Gan, Jacek; de Bie, Fenna; Javaid, Amal M; Hoefges, Anna; Merdler, Michael; Carmichael, Lakeesha; Kim, KyungMann; Bishop, Michael W; Meager, Michael M; Gillies, Steven D; Pandey, Janardan P; Sondel, Paul M
细胞生物学
发表日期：2020
文献求助 收藏

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

表达KIR2DL2和KIR3DL1及其配体（HLA-C1和HLA-Bw4）的滤泡性淋巴瘤患者接受利妥昔单抗治疗后，预后有所改善。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0538-8
Erbe, Amy K; Wang, Wei; Carmichael, Lakeesha; Hoefges, Anna; Grzywacz, Bartosz; Reville, Patrick K; Ranheim, Erik A; Hank, Jacquelyn A; Kim, KyungMann; Seo, Songwon; Mendonca, Eneida A; Song, Yiqiang; Kenkre, Vaishalee P; Hong, Fangxin; Gascoyne, Randy D; Paietta, Elisabeth; Horning, Sandra J; Miller, Jeffrey S; Kahl, Brad; Sondel, Paul M
3D/类器官
淋巴瘤
发表日期：2019
文献求助 收藏

Predictors of Overweight and Obesity in American Indian Families With Young Children

美国印第安家庭中幼儿超重和肥胖的预测因素

期刊:Journal of Nutrition Education and Behavior
影响因子:2.3
doi:10.1016/j.jneb.2018.07.011
Adams, Alexandra K; Tomayko, Emily J; A Cronin, Kate; J Prince, Ronald; Kim, Kyungmann; Carmichael, Lakeesha; Parker, Tassy
肥胖
代谢
发表日期：2019
文献求助 收藏

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

神经母细胞瘤患者的KIR和KIR配体基因型影响基于Dinutuximab的免疫疗法的临床疗效：来自儿童肿瘤协作组的报告

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-1767
Erbe, Amy K; Wang, Wei; Carmichael, Lakeesha; Kim, KyungMann; Mendonça, Eneida A; Song, Yiqiang; Hess, Dustin; Reville, Patrick K; London, Wendy B; Naranjo, Arlene; Hank, Jacquelyn A; Diccianni, Mitchell B; Reisfeld, Ralph A; Gillies, Stephen D; Matthay, Katherine K; Cohn, Susan L; Hogarty, Michael D; Maris, John M; Park, Julie R; Ozkaynak, M Fevzi; Gilman, Andrew L; Yu, Alice L; Sondel, Paul M
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2018
文献求助 收藏

Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel.

使用 FLT PET/CT 对采用 X-82 和多西他赛序贯联合治疗的晚期实体恶性肿瘤进行药效学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-018-3599-3
Scarpelli Matthew, Rampurwala Murtuza, Eickhoff Jens, Carmichael Lakeesha, Heideman Jennifer, Binger Kimberly, Kolesar Jill, Perlman Scott, Harrow Kim, Dukart Gary, Liang Chris, Jeraj Robert, Liu Glenn, Bruce Justine Yang
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer

奥特罗内尔治疗激素受体阳性（HR+）转移性乳腺癌绝经后女性的1b期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-016-0403-2
Rampurwala, Murtuza; Wisinski, Kari B; Burkard, Mark E; Ehsani, Sima; O'Regan, Ruth M; Carmichael, Lakeesha; Kim, KyungMann; Kolesar, Jill; Tevaarwerk, Amye J
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏

A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors

组蛋白去乙酰化酶抑制剂帕比司他治疗低级别神经内分泌肿瘤患者的II期临床试验

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2016-0060
Jin, Ning; Lubner, Sam J; Mulkerin, Daniel L; Rajguru, Saurabh; Carmichael, Lakeesha; Chen, Herb; Holen, Kyle D; LoConte, Noelle K
乙酰化
肿瘤
表观遗传
肿瘤免疫
发表日期：2016
文献求助 收藏

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors

一项针对难治性实体瘤的γ-分泌酶抑制剂RO4929097联合卡培他滨的多中心I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0166-6
LoConte, Noelle K; Razak, Albiruni R A; Ivy, Percy; Tevaarwerk, Amye; Leverence, Rachael; Kolesar, Jill; Siu, Lillian; Lubner, Sam J; Mulkerin, Daniel L; Schelman, William R; Deming, Dustin A; Holen, Kyle D; Carmichael, Lakeesha; Eickhoff, Jens; Liu, Glenn
发表日期：2015
文献求助 收藏

Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography.

采用 (18)F-3'脱氧-3'氟-L-胸苷正电子发射断层扫描/计算机断层扫描评估阿昔替尼在晚期恶性肿瘤患者中的药效学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-015-2779-7
Bruce Justine Yang, Scully Peter Colin, Carmichael Lakeesha L, Eickhoff Jens C, Perlman Scott B, Kolesar Jill Marie, Heideman Jennifer L, Jeraj Robert, Liu Glenn
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

一项针对肾细胞癌和其他晚期实体恶性肿瘤患者的舒尼替尼联合贝伐单抗序贯治疗的I期药效学试验

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-013-2373-9
Bruce, Justine Yang; Kolesar, Jill M; Hammers, Hans; Stein, Mark N; Carmichael, Lakeesha; Eickhoff, Jens; Johnston, Susan A; Binger, Kimberly A; Heideman, Jennifer L; Perlman, Scott B; Jeraj, Robert; Liu, Glenn
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2014
文献求助 收藏